Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells-Reference-Cited by-同舟云学术

Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells

Published:2003-09 Issue:1 Volume:478 Page:39-46
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Yamakawa Tadashi,Tanaka Shun-ichi,Kamei Junzo,Kadonosono Kazuaki,Okuda Kenji

Publisher

Elsevier BV

Subject

Pharmacology

Reference41 articles.

1. Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment;Aalkjaer;J. Hypertens.,1989

2. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation;Beretta;EMBO J.,1996

3. Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells;Bhandari;Kidney Int.,2001

4. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin;Brunn;Science,1997

5. Signal transduction by the hepatocyte growth factor receptor, c-met. Activation of the phosphatidylinositol 3-kinase;Cantley;J. Am. Soc. Nephrol.,1995

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced glycation end products and insulin resistance in diabetic nephropathy;Vitamins and Hormones;2024

2. Angiotensin II as a mediator of renal fibrogenesis;Angiotensin;2023

3. Angiotensin II-Regulated Autophagy Is Required for Vascular Smooth Muscle Cell Hypertrophy;Frontiers in Pharmacology;2019-02-05

4. Ligand-activated PPARδ inhibits angiotensin II-stimulated hypertrophy of vascular smooth muscle cells by targeting ROS;PLOS ONE;2019-01-08

5. Role of Mammalian Target of Rapamycin in Atherosclerosis.;Current Molecular Medicine;2018-09-26